ScrutarSign up free

MDLN SEC Filings

SEC filings for MDLN. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.

All10-K10-Q8-KProxyForm 413D/GLast 12 months
FormFiledAccession
4Hux Investment Pte. Ltd.Oct 13, 2026EDGAR
4Hux Investment Pte. Ltd.Oct 7, 2026EDGAR
4Hux Investment Pte. Ltd.Aug 17, 2026EDGAR
SC 13G/AamendedH&F Corporate Investors X, Ltd. and 8 other reporting personsAug 11, 2026EDGAR
4Hux Investment Pte. Ltd.Aug 11, 2026EDGAR
4Mozart Holdco, Inc.Aug 7, 2026EDGAR
SC 13G/AamendedBlackstone Holdings I/II GP L.L.C. and 15 other reporting personsAug 7, 2026EDGAR
4Hux Investment Pte. Ltd.Aug 7, 2026EDGAR
SC 13GAbigail P. Johnson and 1 other reporting personAug 6, 2026EDGAR
10-QAug 5, 2026EDGAR
8-KAug 5, 2026EDGAR
8-KAIMedline Inc. disclosed that Chief Operating Officer Stephen L. Miller notified the company on July 7, 2026 of his retirement for health-related reasons, effective August 30, 2026.Jul 9, 2026EDGAR
4Abrams William JSee RemarksJun 17, 2026EDGAR
4Shryock Christopher PChief Human Resources OfficerJun 17, 2026EDGAR
4Miller Stephen LChief Operating OfficerJun 17, 2026EDGAR
4Liberman Alexander M.Chief Legal OfficerJun 17, 2026EDGAR
4Laabs Amanda H.Chief Product OfficerJun 17, 2026EDGAR
4Drazin Michael BChief Financial OfficerJun 17, 2026EDGAR
4Golwas Douglas PChief Commercial OfficerJun 17, 2026EDGAR
4Boyle James MChief Executive OfficerJun 17, 2026EDGAR
4GALANTI RICHARD AJun 15, 2026EDGAR
4Sweet Thomas WJun 15, 2026EDGAR
4Bluedorn Todd MJun 15, 2026EDGAR
8-KJun 12, 2026EDGAR
4CORCORAN JESSI LPrincipal Accounting OfficerJun 9, 2026EDGAR
8-KJun 2, 2026EDGAR
4H&F Corporate Investors X, Ltd.Jun 1, 2026EDGAR
4HEALY PATRICK JJun 1, 2026EDGAR
4SCHWARZMAN STEPHEN AJun 1, 2026EDGAR
4Blackstone Management Associates VIII L.P.Jun 1, 2026EDGAR
4H&F Corporate Investors X, Ltd.May 26, 2026EDGAR
SC 13G/AamendedCarlyle Group Inc. and 28 other reporting personsMay 15, 2026EDGAR
SC 13G/AamendedAbu Dhabi Investment Authority and 1 other reporting personMay 7, 2026EDGAR
SC 13G/AamendedH&F Corporate Investors X, Ltd. and 8 other reporting personsMay 7, 2026EDGAR
8-KMay 6, 2026EDGAR
10-QAIMedline reports strong top-line growth (net sales +10.7%) but margin compression, lower operating income, net income and Adjusted EBITDA, largely from tariff costs.May 6, 2026EDGAR
SC 13G/AamendedBlackstone Group Management L.L.C. and 15 other reporting personsMay 1, 2026EDGAR
DEF 14AApr 23, 2026EDGAR
8-KFeb 25, 2026EDGAR
10-KAIMedline's first post-IPO MD&A is upbeat on double-digit sales growth, Prime Vendor momentum, and a large debt paydown funded by IPO proceeds.Feb 25, 2026EDGAR
SC 13GH&F Corporate Investors X, Ltd. and 8 other reporting personsFeb 13, 2026EDGAR
SC 13GCG Subsidiary Holdings L.L.C. and 28 other reporting personsFeb 13, 2026EDGAR
SC 13GBlackstone Inc. and 9 other reporting personsFeb 13, 2026EDGAR
SC 13GMozart Holdco, Inc.Feb 13, 2026EDGAR
SC 13GAbu Dhabi Investment Authority and 1 other reporting personFeb 11, 2026EDGAR
SC 13GGIC Private Limited and 2 other reporting personsDec 29, 2025EDGAR
8-KDec 22, 2025EDGAR
IPO • 424B4Dec 18, 2025EDGAR

SEC filings for companies related to MDLN

BDXBECTON DICKINSON & COBAXBAXTER INTERNATIONAL INCSOLVSolventum CorpCAHCARDINAL HEALTH INC

Never miss a MDLN filing.

Get an email when MDLN files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Source: SEC EDGAR.